
Konet S 250mg/125mg Injection
Marketer
Cureways Remedies
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Konet S 250mg/125mg Injection
Sulfamethoxazole and Trimethoprim Injection (250mg/125mg), a dual-action antibiotic, is indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus limiting infection spread. Administration must be under a physician's direct guidance. Adherence to the prescribed dosage schedule is crucial; complete the entire course, regardless of symptom improvement. Premature cessation may compromise treatment effectiveness. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea, indigestion). Escalating side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) demand prompt emergency care. Disclose all current medications to your doctor prior to initiating treatment. Pregnant or lactating individuals should consult their physician before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Sufficient rest, proper nutrition, and ample hydration are vital for optimal recovery. Your doctor may order lab tests to monitor the medication's effects.
Primary Ingredients of Konet S 250mg/125mg Injection
The provided text is "undefined," therefore no rewriting is possible.
Uses of Konet S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Konet S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Please refrain from self-medication.
Common Side effects of Konet S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Konet S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Konet S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Konet S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone's antibiotic properties disrupt bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, complements this action by counteracting bacterial resistance mechanisms, thus maximizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Konet S 250mg/125mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Konet S (250mg/125mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; clinical data in humans, however, remains scarce.
Breast feedingCAUTION
Administering Konet S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Konet S 250mg/125mg Injection can lead to reduced awareness, visual impairment, drowsiness, and dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Konet S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Individuals with severe hepatic impairment should use Konet S 250mg/125mg Injection cautiously, potentially requiring a modified dosage. Medical advice is recommended. Dosage alteration for Konet S 250mg/125mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Konet S 250mg/125mg Injection :
Omit a Konet S 250mg/125mg Injection dose? Seek medical advice immediately.
Facts to Know About Konet S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
